Steven D Tate, MD
Addiction Medicine · Stanford
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- 1
- 1 carrier
- Office
- 1
Offices
1 location · Stanford Health Care · 3,152 clinicians in this group
Hospitals listed: Stanford Health Care. That is not proof they admit you there this week.
Plans that list them
1 plan · 1 carrier
A missing listing does not mean out of network. Directories change, and a listing does not cover every office. Call Dr. Tate’s office at (650) 723-4000 to confirm they take your plan. Ask about the office you use, its medical group, referrals and appointments.
| Anthem Full Dual Advantage Aligned (HMO D-SNP) | Anthem Blue Cross | Listed | Oct 3, 2026 |
California Medical Board record
Licence A173657 · Current
Licensed to practise in California · since 2021 · expires 2027-07-31 · University of Chicago, Pritzker School of Medicine.
No disciplinary actions, convictions, malpractice judgments or citations in this record.
Hospitals they work in
1 hospital
These rate the hospital, not this clinician. Most measures at most hospitals are no different from the national rate.
- Stanford Health CareStanford, CAAcute Care Hospital · Voluntary non-profit - Private · Has an emergency departmentPart of Stanford Health Care, which runs 3 hospitalsHome of Stanford Cancer Institute, a National Cancer Institute designated comprehensive cancer centrePatients rate it 4 of 5 · 83% would definitely recommend itOverall rating: 5 of 5 starsWorse than the national rate — Perioperative pulmonary embolism or deep vein thrombosis rate: 5.31 (4.24 to 6.37) · 8,661 cases, Jul 2022 – Jun 2024Worse than the national rate — Rate of inpatient admissions for patients receiving outpatient chemotherapy: 14.1 (12.7 to 15.7) · 2,191 cases, Jan 2024 – Dec 2024Better than the national rate — Postoperative respiratory failure rate: 4.08 (1.95 to 6.21) · 5,296 cases, Jul 2022 – Jun 2024Better than the national rate — Catheter Associated Urinary Tract Infections (ICU + select Wards): 0.317, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.446, Oct 2024 – Sep 2025Better than the national rate — SSI - Colon Surgery: 0.241, Oct 2024 – Sep 2025Better than the national rate — Ratio of unplanned hospital visits after hospital outpatient surgery: 0.7 (0.6 to 0.9) · 3,348 cases, Jan 2024 – Dec 2024
See every measure and the patient survey for Stanford Health Care
Behind the star rating — Deaths: 5 better, 3 the same, 0 worse of 8 measures. Safety: 3 better, 5 the same, 0 worse of 8 measures. Readmissions: 2 better, 5 the same, 4 worse of 11 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 5.31 (4.24 to 6.37) · 8,661 cases | Worse | Jul 2022 – Jun 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 14.1 (12.7 to 15.7) · 2,191 cases | Worse | Jan 2024 – Dec 2024 |
| Postoperative respiratory failure rateComplications and deaths | 4.08 (1.95 to 6.21) · 5,296 cases | Better | Jul 2022 – Jun 2024 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.317 | Better | Oct 2024 – Sep 2025 |
| Clostridium Difficile (C.Diff)Infections | 0.446 | Better | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 0.241 | Better | Oct 2024 – Sep 2025 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 0.7 (0.6 to 0.9) · 3,348 cases | Better | Jan 2024 – Dec 2024 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 1.06 (0.45 to 1.67) · 5,374 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 0.86 (0.72 to 1) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 166.09 (137.88 to 194.3) · 470 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for CABG surgery patientsComplications and deaths | 1.1 · 192 cases | None | Jul 2022 – Jun 2025 |
| Death rate for COPD patientsComplications and deaths | 6.4 · 146 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 9.7 · 253 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 6.3 · 880 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 10.3 · 935 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 8.7 · 501 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 2.1 · 7,730 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.13 (0 to 0.27) · 20,799 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.28 (0.14 to 0.43) · 23,182 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 0.94 (0.2 to 1.68) · 5,694 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.36 (1.54 to 3.19) · 7,846 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 5.2 (3.76 to 6.64) · 5,603 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.38 (0.23 to 2.53) · 2,211 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.52 (0.21 to 0.83) · 19,915 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 3.6 · 416 cases | None | Apr 2023 – Mar 2025 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.869 | No different | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 0.857 | No different | Oct 2024 – Sep 2025 |
| SSI - Abdominal HysterectomyInfections | 0.368 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 16.2 · 247 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 20.5 · 1,021 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | 47.8 · 258 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | -1.6 · 990 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 20.8 · 976 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 16.5 · 959 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 5.2 (4.4 to 6.2) · 2,191 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 5.1 · 425 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for CABGUnplanned return visits | 9.6 · 158 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 19.6 · 183 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 12.7 (10.4 to 15.4) · 4,578 cases | No different | Jan 2022 – Dec 2024 |
What patients said (6,810 patients answered, 25% of those asked)
| Cleanliness | 4 |
| Nurse communication | 4 |
| Doctor communication | 4 |
| Communication about medicines | 3 |
| Discharge information | 4 |
| Overall hospital rating | 4 |
| Quietness | 2 |
| Recommend hospital | 5 |
| Room was "always" clean | 75% |
| Nurses "always" communicated well | 82% |
| Doctors "always" communicated well | 81% |
| Staff "always" explained | 63% |
| Yes, staff "did" give patients this information | 89% |
| Yes, staff "did" give patients information about help after discharge | 89% |
| Doctors "always" explained things so they could understand | 76% |
| Doctors "always" listened carefully | 80% |
| Doctors "always" treated them with courtesy and respect | 87% |
| Patients who gave a rating of "9" or "10" (high) | 79% |
| Staff "always" explained new medications | 76% |
| Nurses "always" explained things so they could understand | 77% |
| Nurses "always" listened carefully | 79% |
| Nurses "always" treated them with courtesy and respect | 88% |
| "Always" quiet at night | 53% |
| "YES", patients would definitely recommend the hospital | 83% |
| Staff "always" explained possible side effects | 50% |
| Yes, staff "did" give patients information about possible symptoms | 90% |
Original Medicare doctor bills
$30,656
Medicare paid this office $30,656 for 88 people.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
| Return visit (30+ min) | 22 | $11,695 | $122 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 37 | $6,164 | $154 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 29 | $6,134 | $106 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 11 | $1,053 | $70 |
Who their Medicare patients are
88 Original Medicare patients in 2024. Average age 64 · Under 65 42% · Women 46% · Also on Medicaid 57% · Health risk score 2.95. Sicker patients than 9 in 10 peers; the typical addiction medicine clinician is at 1.56.
Conditions among them: High blood pressure 75% · Depression 64% · Chronic kidney disease 36% · Diabetes 34% · Heart failure 34% · Coronary heart disease 31% · COPD 27% · Dementia 22% · Cancer 19% · Atrial fibrillation 18%.
The office billed $123,764, Medicare allowed $38,773 and paid $30,656; for 259 services of 19 kinds.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Year by year
| 2024 | 88 | 259 | 64 | 2.95 | $123,764 | $30,656 |
| 2023 | 84 | 332 | 63 | 2.85 | $146,407 | $30,167 |
| 2022 | 42 | 153 | 60 | 2.50 | $64,197 | $13,157 |
Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.
See the services billed each year
2023: 5 services
| Return visit (30+ min) | 16 | $9,489 | $117 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 37 | $5,938 | $152 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 23 | $4,071 | $107 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 23 | $2,638 | $68 |
| Telehealth originating site facility fee | 21 | $1,369 | $21 |
2022: 4 services
| Return visit (30+ min) | 11 | $4,291 | $123 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 12 | $2,482 | $177 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 11 | $1,085 | $64 |
| Telehealth originating site facility fee | 11 | $584 | $22 |
Medicaid work
$11,920 in 2024
Medicaid paid $11,920 for 202 billed services this clinician did in 2024, up to 17 people in a month for one service.
Medicaid and CHIP claims where this clinician did the service, fee-for-service and managed care together. Any month with fewer than 11 patients is hidden, so small Medicaid practices undercount.
| 1ST HOSP IP/OBS HIGH 75 | 69 | $6,012 |
| SBSQ HOSPITAL IP/OBS CARE HIGH MDM 50 MINUTES | 117 | $5,293 |
| SBSQ HOSPITAL IP/OBS CARE MOD MDM 35 MINUTES | 16 | $615 |
| 2024 | 202 | 3 | 17 | $11,920 |
| 2023 | 104 | 3 | 14 | $5,102 |
| 2022 | 84 | 2 | 22 | $6,119 |
See the largest Medicaid services in earlier years
2023
| 1ST HOSP IP/OBS HIGH 75 | 38 | $2,240 |
| SBSQ HOSPITAL IP/OBS CARE HIGH MDM 50 MINUTES | 32 | $1,702 |
| SBSQ HOSPITAL IP/OBS CARE MOD MDM 35 MINUTES | 34 | $1,160 |
2022
| 1ST HOSP IP/OBS HIGH 75 | 69 | $5,364 |
| SBSQ HOSPITAL IP/OBS CARE HIGH MDM 50 MINUTES | 15 | $755 |
Drugs they prescribed that Part D paid
$4,708
Pharmacies billed $4,708 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
81 generic and fewer than 11 brand-name prescriptions · $4,708 in drug cost.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Buprenorphine-Naloxone | 32 | $2,709 | $85 |
Year by year
| 2024 | 83 | 17 | None | None | $4,708 |
| 2023 | 77 | 19 | None | None | $11,323 |
| 2022 | 248 | 58 | None | None | $38,039 |
| 2021 | 635 | 97 | 0% (0) | 22% | $94,299 |
| 2020 | 983 | 118 | 0% (0) | 22% | $134,609 |
| 2019 | 365 | 85 | 0% (0) | None | $35,677 |
| 2018 | 75 | 17 | 0% (0) | None | $5,396 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 1 drug
| Diazepam | 11 | $76 | $7 |
2022: 5 drugs
| Buprenorphine-Naloxone | 77 | $8,940 | $116 |
| Varenicline | 12 | $4,438 | $370 |
| Buprenorphine | 23 | $807 | $35 |
| Gabapentin | 14 | $219 | $16 |
| Buspirone | 11 | $101 | $9 |
2021: 21 drugs
| Trulicity | 21 | $23,094 | $1,100 |
| Xarelto | 12 | $9,232 | $769 |
| Jardiance | 12 | $6,905 | $575 |
| Farxiga | 11 | $6,195 | $563 |
| Novolin 70-30 Flexpen | 13 | $3,579 | $275 |
| Atorvastatin | 50 | $891 | $18 |
| Chlorthalidone | 11 | $376 | $34 |
| Gabapentin | 20 | $372 | $19 |
| Amlodipine Besylate | 36 | $250 | $7 |
| Allopurinol | 13 | $214 | $16 |
| Metformin | 15 | $211 | $14 |
| Fluticasone Propionate | 19 | $207 | $11 |
| Losartan | 14 | $192 | $14 |
| Rosuvastatin | 16 | $188 | $12 |
| Omeprazole | 17 | $149 | $9 |
| Pantoprazole | 12 | $136 | $11 |
| Sertraline | 13 | $129 | $10 |
| Torsemide | 11 | $94 | $9 |
| Metformin Hcl Er | 14 | $85 | $6 |
| Metoprolol | 12 | $85 | $7 |
| Furosemide | 12 | $36 | $3 |
2020: 24 drugs
| Eliquis | 27 | $21,098 | $781 |
| Humalog Kwikpen U-100 | 21 | $13,377 | $637 |
| Jardiance | 15 | $8,100 | $540 |
| Lantus Solostar | 16 | $6,457 | $404 |
| Invokana | 12 | $5,646 | $471 |
| Atorvastatin | 74 | $1,017 | $14 |
| Ultra-Fine Mini Pen Needle | 15 | $706 | $47 |
| Metoprolol | 20 | $377 | $19 |
| Levothyroxine | 11 | $343 | $31 |
| Chlorthalidone | 14 | $309 | $22 |
| Gabapentin | 25 | $252 | $10 |
| Lisinopril | 33 | $187 | $6 |
| Tamsulosin | 17 | $171 | $10 |
| Amlodipine Besylate | 58 | $171 | $3 |
| Metformin | 19 | $162 | $9 |
| Losartan | 22 | $142 | $6 |
| Valsartan-Hydrochlorothiazide | 12 | $117 | $10 |
| Amiodarone | 11 | $113 | $10 |
| Hydrochlorothiazide | 19 | $102 | $5 |
| Torsemide | 12 | $95 | $8 |
| Metformin Hcl Er | 17 | $80 | $5 |
| Carvedilol | 19 | $61 | $3 |
| Furosemide | 12 | $47 | $4 |
| Omeprazole | 11 | $43 | $4 |
2019: 6 drugs
| Atorvastatin | 23 | $455 | $20 |
| Levothyroxine | 11 | $371 | $34 |
| Lisinopril | 17 | $313 | $18 |
| Losartan | 12 | $148 | $12 |
| Gabapentin | 16 | $87 | $5 |
| Hydrochlorothiazide | 11 | $35 | $3 |
Checkups this office reported
Medicare did not publish checkup rates for this clinician.
- Medicare’s overall office score
- 76.5 / 100
- Scores the office’s reporting and systems. It is not a grade for how the doctor treats you.
Professional record
- NPI
- 1972090280
- Licence
- CA A173657California A173657: Current · expires 2027-07-31
- Trained
- University of Chicago, Pritzker School of Medicine, 2018
- Group
- Stanford Health Care
- Video visits
- Lists video visits
- Gender
- Male
More record details
- Sole proprietor
- No
- Taxonomy
- Federal specialty code 2083A0300X (2083A0300X); Internal medicine (207R00000X)
- Mailing address
- 300 Pasteur Dr, Stanford, CA, 94305
- NPI first listed
- 2018-04-23
- NPI last updated
- 2024-06-24
- NPI record certified
- 2024-06-24
This is when the NPI record was last certified, not a medical board exam.